Novartis deal on the rocks, page-13

It does seem far fetched. But a rebuttal more then "outright lies" may be in order.

I understand msb were unlikely to me the projected primary end point but there could be some solid data that helps msb and NIH in finding an effective target group
In my opinion, the credibility has been smashed from the science because of the wild expectations.

Until the data is unblinded we won't know if and how effective the technology is.

I like what Dr Perrin said in the YouTube video about the Heart trail. Im paraphrasing but," it's like being in a cave with a flashlight".

We are still learning the mechanisms of the technology and target audience.

Its a race for all companies to gather evidence and deliver to market.

I don't know where MSB stand now. But I know alot further then most of us wanted.